news tirzepatide 🎉 GLP-1's To The Rescue Again? 🎉 People with type 2 diabetes and heart disease who take have 33 percent fewer heart attacks than people taking other diabetes drug. At least semaglutide essence trial for Orange Style:Standard (Dots)

news tirzepatide 🎉 GLP-1's To The Rescue Again? 🎉 People with type 2 diabetes and heart disease who take have 33 percent fewer heart attacks than people taking other diabetes drug. At least semaglutide essence trial for Orange Style:Standard (Dots)

semaglutide essence trial for MASH in #ESSENCE #Semaglutide hits both primary endpoints in NASH trial 📍62.9% resolved steatohepatitis (vs 34.3% placebo) 📍36.8% showed fibrosis improvement (vs 22.4% placebo) 📍Combined response: 32.7% vs

Today we’re talking about the health benefits of intermittent fasting

Orange

Style:Standard (Dots)

I am not going to assign a universal range here